Morgan Kohler

Publications:

Is this you?

Claim your profile to connect with sources, showcase your work, and earn extra income just by writing great stories.

Featured Articles

Finding The Therapeutic Window: Using Single-Cell Biology To Build More Selective T-Cell Engagers

A conversation between Cyril Konto, MD, CEO, Shennon Biotechnologies, and The development of precision immunotherapies against solid tumors requires researchers to overcome the fundamental challenges, from identifying differentiated targets, to finding hi... See more

cellandgene.com•Morgan Kohler•Oct 6, 2026

Bylined Articles

HARO Queries

Seeking scientists, academics, biotech experts for byline on drug discovery

Health and Pharma

Deadline: May 31st, 2026 11:59 PM ET

•

Drug Discovery Online

•

16 responses

HARO Queries

Portfolio

Is this you?

Claim your profile to connect with sources, showcase your work, and earn extra income just by writing great stories.

Claim your profile

Social Media

Pitching Guidelines

Keep it short (under 200 words)
Include credentials and links
Use subject lines with query title

Pitching Guidelines

Quick Stats

Followers

Articles1

Last Article2 days ago

Stats

Education

HARO Queries

Seeking scientists, academics, biotech experts for byline on drug discovery

Health and Pharma

Deadline: May 31st, 2026 11:59 PM ET

•

Drug Discovery Online

•

16 responses

Morgan Kohler

Is this you?

Featured Articles

Finding The Therapeutic Window: Using Single-Cell Biology To Build More Selective T-Cell Engagers

HARO Queries

Seeking scientists, academics, biotech experts for byline on drug discovery

Is this you?

Connect with journalists.

Connect with journalists.

Featured Articles

Finding The Therapeutic Window: Using Single-Cell Biology To Build More Selective T-Cell Engagers

HARO Queries

Seeking scientists, academics, biotech experts for byline on drug discovery